Intercept Pharmaceuticals, Inc. (ICPT) has a market capitalization of $794.69M and trades at $19.00. The 52-week range is 8.82-21.86.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of 5.6, Earnings Per Share (EPS) of $3.41, annual revenue of $285.71M.
The stock has a beta of 0.88, operates in the Healthcare sector.
